766-FR) inhibits Recombinant Human FGF acidic (Catalog #
232-FA) induced proliferation in the NR6R-3T3 mouse fibroblast cell line in a dose-dependent manner (orange line) as measured by Resazurin (Catalog #
AR002) . Inhibition of Recombinant Human FGF acidic (0.3 ng/mL) activity elicited by Recombinant Human FGF R3 (IIIc) Fc Chimera (6 ng/mL) is neutralized (green line) by increasing concentrations of Human FGF R3 Monoclonal Antibody (Catalog # MAB7661). The ND
50 is typically 2.5-15 ng/mL in the presence of heparin (10 µg/mL)." class="big_lightbox">

766-FR) inhibits Recombinant Human FGF acidic (Catalog #
232-FA) induced proliferation in the NR6R-3T3 mouse fibroblast cell line in a dose-dependent manner (orange line) as measured by Resazurin (Catalog #
AR002) . Inhibition of Recombinant Human FGF acidic (0.3 ng/mL) activity elicited by Recombinant Human FGF R3 (IIIc) Fc Chimera (6 ng/mL) is neutralized (green line) by increasing concentrations of Human FGF R3 Monoclonal Antibody (Catalog # MAB7661). The ND
50 is typically 2.5-15 ng/mL in the presence of heparin (10 µg/mL)." alt="Recombinant Human FGF R3 (IIIc) Fc Chimera (Catalog #
766-FR) inhibits Recombinant Human FGF acidic (Catalog #
232-FA) induced proliferation in the NR6R-3T3 mouse fibroblast cell line in a dose-dependent manner (orange line) as measured by Resazurin (Catalog #
AR002) . Inhibition of Recombinant Human FGF acidic (0.3 ng/mL) activity elicited by Recombinant Human FGF R3 (IIIc) Fc Chimera (6 ng/mL) is neutralized (green line) by increasing concentrations of Human FGF R3 Monoclonal Antibody (Catalog # MAB7661). The ND
50 is typically 2.5-15 ng/mL in the presence of heparin (10 µg/mL)." class="big_thumb" />